Novel Coronavirus (SARS-CoV-2/COVID-19)
The Centers for Medicare & Medicaid Services (CMS) Oct. 28 announced an interim final rule establishing additional Medicare hospital payment to support Medicare beneficiaries’ access to COVID-19 vaccines and new treatments when they become available.
Congress is back in Washington, D.C., for its “lame-duck” session, in which lawmakers will take up pressing, end-of-year business. Funding for the federal government, as well as other key health care provisions, are set to expire Dec. 11.
David Zaas, M.D., chief clinical officer for MUSC Health in South Carolina and CEO of its Charleston Division, talks with Nancy Foster, AHA vice president for quality and patient safety, about strategies and tools to address burnout as health care professionals continue to care for COVID-19…
The Biden Administration recently released a series of Executive Orders (EOs) related to the COVID-19 pandemic. One EO includes provisions for the Department of Labor and the Occupational Safety and Health Administration (OSHA) to consider whether an Emergency Temporary Standard (ETS), including…
As the COVID-19 pandemic has persisted and again surged across the country, infecting more than 10 million people and resulting in over a quarter million deaths, America’s hospitals and health systems continue to face historic challenges. Since the start of the pandemic, hospitals and health…
As the COVID-19 pandemic has persisted and again surged across the country, infecting more than 10 million people and resulting in nearly a quarter million deaths, America’s hospitals and health systems continue to face historic challenges. Since the start of the pandemic, hospitals and health…
The Food and Drug Administration issued an emergency use authorization for the first serology test to identify individuals with neutralizing antibodies from recent or prior infection with the virus that causes COVID-19.
In a study of 106,543 patients hospitalized for COVID-19 between March and July, 9% were readmitted to the same hospital within two months of discharge, the Centers Disease Control and Prevention reported.
Pfizer Inc. announced that BNT162b2, its mRNA-based vaccine candidate, is more than 90% effective in preventing COVID-19, based on early data that has yet to be peer-reviewed.
The Department of Health and Human Services should fully reinstate its June COVID-19 Provider Relief Fund reporting requirements, AHA said again in a letter to the agency. On Oct. 22, the department partially restored the requirements, but not the ability of hospitals to calculate lost revenue on a…